ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,994,000 | +68.1% | 46,449 | +22.6% | 0.00% | +50.0% |
| Q2 2021 | $4,756,000 | +0.7% | 37,900 | +8.8% | 0.00% | 0.0% |
| Q1 2021 | $4,723,000 | +7.9% | 34,831 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $4,376,000 | -3.7% | 34,201 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $4,543,000 | +24.6% | 40,371 | +5.5% | 0.00% | 0.0% |
| Q2 2020 | $3,646,000 | +45.3% | 38,267 | +37.0% | 0.00% | +100.0% |
| Q1 2020 | $2,510,000 | +80.4% | 27,938 | +6.4% | 0.00% | 0.0% |
| Q4 2019 | $1,391,000 | +58.1% | 26,251 | +17.8% | 0.00% | – |
| Q3 2019 | $880,000 | +15.8% | 22,279 | +20.4% | 0.00% | – |
| Q2 2019 | $760,000 | -8.0% | 18,502 | +4.3% | 0.00% | – |
| Q1 2019 | $826,000 | +14.2% | 17,744 | +6.8% | 0.00% | -100.0% |
| Q4 2018 | $723,000 | -6.6% | 16,608 | +22.8% | 0.00% | 0.0% |
| Q3 2018 | $774,000 | +17.6% | 13,521 | -0.3% | 0.00% | 0.0% |
| Q2 2018 | $658,000 | +16.5% | 13,565 | -6.2% | 0.00% | – |
| Q1 2018 | $565,000 | -21.6% | 14,454 | -14.8% | 0.00% | -100.0% |
| Q4 2017 | $721,000 | +22.6% | 16,956 | +6.9% | 0.00% | – |
| Q3 2017 | $588,000 | +84.9% | 15,862 | +51.5% | 0.00% | – |
| Q2 2017 | $318,000 | +26.2% | 10,470 | +9.7% | 0.00% | – |
| Q1 2017 | $252,000 | +2.0% | 9,547 | -1.1% | 0.00% | – |
| Q4 2016 | $247,000 | +71.5% | 9,653 | +144.1% | 0.00% | – |
| Q3 2016 | $144,000 | -0.7% | 3,954 | -6.2% | 0.00% | – |
| Q2 2016 | $145,000 | +33.0% | 4,214 | +4.3% | 0.00% | – |
| Q1 2016 | $109,000 | -25.9% | 4,041 | +33.8% | 0.00% | – |
| Q4 2015 | $147,000 | +101.4% | 3,021 | 0.0% | 0.00% | – |
| Q3 2015 | $73,000 | -21.5% | 3,021 | 0.0% | 0.00% | – |
| Q2 2015 | $93,000 | -21.2% | 3,021 | 0.0% | 0.00% | – |
| Q1 2015 | $118,000 | +0.9% | 3,021 | 0.0% | 0.00% | – |
| Q4 2014 | $117,000 | +20.6% | 3,021 | -7.6% | 0.00% | – |
| Q3 2014 | $97,000 | – | 3,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |